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Abstract
Yeasts represent a very diverse group of microorganisms, and even strains that are clas-
sified as the same species often show a high level of genetic divergence. Yeasts biodi-
versity is closely related to their applicability. Biotechnological importance of yeast is 
almost immeasurable. For centuries, people have exploited its enzymatic potential to 
produce fermented food as bread or alcoholic beverages. Admittedly, yeasts application 
was initially instinctual, but with science and technology development, these microor-
ganisms got the object of thorough scientific investigations. It must be recognized that 
yeast represents an excellent scientific model because of its eukaryotic origin and knowl-
edge of genetics of yeast cells as well as metabolism examined in detail. In 1996, the 
genome of baker yeast Saccharomyces cerevisiae has been elucidated, what opened the 
opportunity for the global study of the expression and functioning of the eukaryotic 
genome. Also, currently, an international team is working on the synthesis of the 16 
yeast chromosomes by synthetic biology tools, and the results are expected till the end of 
the year. Nowadays, yeast is regarded as a versatile tool for biotechnological purposes.
Keywords: fermentation, SCP, biocatalysis, molecular biology applications—fundamentals
1. Introduction
1.1. Yeasts: commercial applications
Yeasts have a wide range of applications mainly in food industry (wine making, brew-
ing, distilled spirits production, and baking) and in biomass production (single-cell pro-
tein [SCP]). More recently, yeast has also been used in the biofuel industry and for the 
production of heterologous compounds. Obviously, their main application arises from the 
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 metabolic capacity to carry out the transformation of sugars into ethyl alcohol and carbon 
dioxide under anaerobic conditions. Moreover, a large number of secondary flavor com-
pounds are created what implies on organoleptic attributes of particular food products. 
However, it would be misguided to trivialize their metabolic capacities only to fermentative 
activity. The main factors influencing yeast metabolism are the oxygen availability and the 
type of carbon source. Many yeast strains can function under both anaerobic as well as aer-
obic conditions of environment, switching their metabolism types easily [1]. Obviously, the 
courses of main metabolic pathways are conserved, but some regulative mechanisms attract 
the attention, denoting unusual metabolism flexibility [2]. In food industry, Saccharomyces 
cerevisiae is the genus of yeast most frequently used, whereas Candida, Endomycopsis, and 
Kluyveromyces are crucial for SCP production. Yeast strains of industrial importance are 
carefully selected from the immense natural biodiversity and their properties improved 
according to process outcome. Both classical approaches as well as modern strategies of 
gene manipulations are applied to generate variants relevant to work under industrial spe-
cific conditions [3, 4]. Strains alterations concern not only the route of fermentations step 
and its direct yield but also facilitation of product recovery procedures and finally the best 
quality of particular end product. These nonpathogenic strains with both genotypic and 
phenotypic stability should have short-generation time and low nutritional requirements. 
They should perform the fermentation process quickly to minimize the contamination risk. 
Additionally, they should be tolerant of a wide range of physiological stresses, such as low 
pH, high ethanol concentration, and high osmotic stress.
The enzymatic power of yeast is central to beer manufacturing (Figure 1). Industrial species 
are carefully selected, nonsporulated polyploides that do not perform sexual reproduction 
process [5].
Brewer’s yeasts are divided into two separate categories: top-fermenting yeast (ale) and bot-
tom-fermenting one (lager). Both yeast types have similar cell morphology, but they differ 
in some physiological and metabolic features [6], what closely corresponds to the process 
conditions and type of end product. Fermentation of ale yeast is carried out at room tem-
perature and results in beers with a characteristic fruity aroma. In the case of lager yeast, the 
fermentation temperature is lower, and therefore, this step takes longer than fermentation 
with ale strains [7]. The share of aerobic respiration in yeast metabolism is higher in case of 
ale strains than in lager yeast. Both top-fermenting and bottom-fermenting yeast belong to 
the genus Saccharomyces. Ale-brewing yeasts are genetically more diverse and classified as 
Saccharomyces cerevisiae, whereas the taxonomy of the lager strains has undergone several 
changes. Initially, bottom-fermenting yeast was classified as Saccharomyces carlsbergensis, 
but due to the application of modern taxonomic approaches, the species S. carlsbergensis 
were included as a part of Saccharomyces pastorianus taxon. On the basis of genetic studies, 
S. pastorianus strains are now considered as allopolyploid interspecies hybrids of S. cerevi-
siae and S. bayanus [8]. From technological point of view, beside the high fermentative activ-
ity of yeast cells and tolerance for several environmental stresses, the aptitude for asexual 
aggregation known as flocculation seemed to be especially important, because this ability 
causes the yeast to sediment to the bottom of the fermenter at the end of fermentation step, 
what simplifies downstream processing [9, 10].
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Various yeast species constitute the predominant microbial group of natural microbiota 
of fruits ecosystems, what is the reason of fast and spontaneous fermentation of juices or 
musts resulted in wine production. Yeast colonizing various fruits belongs to the genera 
Saccharomyces, Brettanomyces (its sexual form (teleomorph) Dekkera), Candida, Cryptococcus, 
Debaromyces, Hanseniaspora (anamorph Kloeckera), Hansenula, Kluyveromyces, Pichia, 
Rhodotorula, Torulaspora, Schizosaccharomyces, and Zygosaccharomyces [11]. It goes without say-
ing that most fermented products are generated by a mixture of microbes. These microbial 
consortia perform various biological activities responsible for the nutritional, hygienic, and 
aromatic qualities of the product [12]. Doubtlessly, yeast plays a principal role in wine mak-
ing both in domestic environment as well as in commercial scale (Figure 2). Nonconventional 
yeast (non-Saccharomyces species) dominates during early and middle stages of fermentation 
process, whereas the latter phase of natural process is mediated by Saccharomyces cerevisiae. 
The raw material of particular importance in global wine making is grapes that are harvested 
at specific stages of ripeness depending on the style of wine to be made.
Figure 1. Beer production process.
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Once again yeast enzymatic power is crucial for the product chemical profile—except for 
ethanol biosynthesis, the creation of flavor compounds and fragrances from substrates abun-
dant in fruits implies the organoleptic features of particular wine product. During the degra-
dation of grape sugars, amino acids, fatty acids, terpenes, and thiols, some by-products like 
glycerol, carboxylic acids, aldehydes, higher alcohols, esters, and sulfides are formed, and 
their synthesis is largely dependent on the peculiarities of the strains used [13, 14]. In 1965, the 
first two commercially active dried wine yeasts called Montrachet and Pasteur Champagne 
were produced for a large Californian winery [15]. Nowadays, modern winegrowers rou-
tinely use selected yeast starters in practice. These microorganisms dominate native yeast spe-
cies and give desired direction of chemical transformations occurring in musts and allow to 
obtain product of predictable quality [16]. Presently exploited commercially available starters 
have been created as a result of naturally occurring phenomenon called “genome renewal” 
as well as planned processes of genetic improvement [17] followed by a careful selection for 
their good fermentation performance. Genome renewal hypothesis in the standard version 
assumes that infrequent sexual cycles, characterized by a high degree of selfing, can help to 
purge deleterious alleles and fix beneficial alleles, thus helping to facilitate adaptation in yeast 
[18]. This hypothesis had to be re-evaluated [19] due to the fact that in the case of many envi-
ronmental isolates, very high levels of genomic heterozygosity had been observed [20, 21]. 
Presently, the majority of commercial wine yeast comprises strains of Saccharomyces cerevisiae, 
including those described by enologists as S. bayanus, which has been re-identified in most 
cases as S. cerevisiae [22, 23]. The growing demand for more diversified wines or for specific 
characteristics has led to the exploration of new species for wine making [24–26]. This non-
conventional yeast may contribute to the wine's organoleptic characteristic by producing a 
broad range of unique secondary metabolites and secreting particular enzymes or exhibiting 
Figure 2. Wine production process.
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others substantial features (release of mannoproteins, contributions to color stability etc.) [27]. 
The wine industry currently proposes starters of a few nonconventional yeast (Torulaspora 
delbrueckii, Metschnikowia pulcherrima, Pichia kluyveri, Lachancea thermotolerans, etc.) [28]. Yeast 
variants used as starters must qualify for commercial application. The list of desired proper-
ties is very long and includes both fermentation characteristics as well as flavor characteristics 
(e.g., low sulphide/dimethyl sulphide/thiol formation, liberation of glycosylated flavor pre-
cursors, low higher alcohol production, etc.), metabolic properties with health implications 
(low formation of sulphite, biogenic amines, or urea) and technological properties (e.g., high 
sulphite tolerance, low foam formation, flocculation properties, etc.) [29].
Another example of Saccharomyces cerevisiae strains of commercial interest encompasses dis-
tiller’s yeasts, applied in industry where alcohol fermentation is followed by distillation. In 
this industry type, spontaneous fermentations are not practiced, and specific yeast is inocu-
lated into fermenter. Starters used for distilled beverages (aquavit, gin, vodka, whisky, rum, 
tequila, cognac, brandy, and kirsch) commercial production should exhibit exquisitely inten-
sive anaerobic metabolism, what should result not only in high ethanol productivity but also 
in the high level of cellular tolerance to this product. Additionally, thermostable variants tol-
erant to acids and increased osmotic pressure are in greater demand for distillers [30]. Since 
many years, there has been a rising interest in new variants that are able to degrade starch. 
Many attempts have been made to produce ethanol from starch using recombinant haploid 
strains that express amylolytic enzymes, due to the simplicity of genetic manipulation of 
these strains. However, it is difficult to use laboratory haploid strains in practice because their 
fermentation characteristics are not as good as those of industrial polyploidy strains [31, 32].
In addition to alcoholic beverages production, enzymatic power of yeasts is also essential for 
baking industry, where concentrated yeast biomass is used as a starter in dough fermentation 
in order to produce bread and other bakery products. Commercially available baker’s yeast 
forms include fresh compressed biomass, dehydrated cells (dry yeast), and lyophilized cells 
(instant). Fermentation of dough substrates leads to ethanol production as well as number of 
volatile and nonvolatile compounds that have an important contribution to the flavor of bread 
[33]. As a result of carbohydrates (maltose mainly), fermentation carbon dioxide is generated 
what increases the dough volume and is responsible for crumb texture. Baker’s yeast is sim-
ply brewery yeast produced via submerged fermentation process carried out in the presence 
of oxygen (Figure 3). Aerobic conditions favor yeast cells production, which is not of interest 
to ethanol producers, but is important when large amount of cells mass must be produced.
The main ingredient of industrial production medium used in yeast production factories are 
beet or cane molasses, mainly because of the low cost of this waste products and high sucrose 
content. In most cases, the industrial production is a multistage process carried out under batch 
or fed-batch conditions with sequential stages differing in fermenter size, performed under 
controlled intense aeration [34]. Aeration is generally considered as the most important single 
factor to increase yeast yield and numerous studies have been carried out to investigate the 
optimization of particular technological solutions [35]. It should be underlined, the particular 
uniqueness of yeast metabolism—baker’s yeast must exhibit efficient respiratory metabolism 
during yeast manufacturing, which determines biomass yield, but at the same time, cells must 
Yeast as a Versatile Tool in Biotechnology
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possess strong fermentative potential in order to produce excellent bakery products. During 
the fermentation of dough yeast cells is exposed to numerous environmental stresses (baking 
associated stresses) such as freeze thaw, high sugar concentrations, air drying, and oxidative 
stresses [36]. Nor should it be surprising that industrial starters should be characterized by 
appropriate stress tolerance. Yeasts certainly have evolved some mechanisms of adaptation, 
but if the level of stress will increase too much, their enzymatic potential will be restricted. It 
has been demonstrated that two molecules: trehalose and proline are extremely important for 
yeast stress tolerance, so the engineering of their metabolism is a promising approach to the 
development of stress-tolerant yeast strains relevant to industrial use [37].
Next long-standing industrial processes involving yeast are the production of single-cell 
protein (SCP)—alternative source of high nutritional value proteins used as a food or feed 
supplements. Idea of such protein concentrate production was born in response to growing 
Figure 3. Baker’s yeast production process.
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human population in the world and worldwide protein deficiency [38]. SCP manufacture 
includes simply the cell mass obtaining by way of the application of cheap, waste raw materi-
als to cultivate various nonpathogenic microorganisms (bacteria, fungi, algae) under condi-
tions of submerged (rarely solid-state) fermentation. Besides its high protein content (about 
60–82% of dry matter), SCP also contains fats, carbohydrates, nucleic acids, vitamins, and 
minerals [39]. In practice, several technologies were evaluated, products commercialized and 
currently obtained SCP found the application primarily in animal feeding. However, baker’s 
yeast mentioned above can be considered also as an example of particular SCP preparation. 
Many fungal species are used as protein-rich food. Most popular among them are the yeast 
species Candida, Hansenula, Pichia, Torulopsis, and Saccharomyces [40], but also, marine yeast is 
considered now as a valuable source of protein [41, 42]. Yeast-derived SCP has desired nutri-
tional value and contains essential amino acids—above all sulfur containing amino acids. It 
is also significant that people accept yeast as a food source, because of its historical impact. 
The main disadvantage of this preparation limiting the utilization as food is the nucleic acid 
content what is associated with additional purification step in downstream processing [43] as 
well as with external mannoprotein layer of yeast cell wall what impedes the digestion.
Yeast can also be considered as an alternative source of lipids. Some species are capable of syn-
thesis and accumulation of over 20% of biomass in form of neutral lipids and for that reason are 
called “oleaginous.” Under optimal growth conditions and/or as a result of genetic improve-
ment, the level of lipid accumulation can reach even 70%. Oleaginous yeast includes species of 
Candida, Cryptococcus, Pichia (Hansenula), Lipomyces, Pseudozyma, Rhodosporidium, Rhodotorula, 
Trichosporon, Trigonopsis, Yarrowia, and Saccharomycopsis [44]. The ability of these yeast species 
to accumulate high quantities of lipids offers the commercial potential for production of single-
cell oil (SCO). Microbial oils can serve both as alternative edible oils for food industry as well 
as substrates used in synthesis of the oleochemicals such as fuels, soaps, plastics, paints, deter-
gents, textiles, rubber, surfactants, lubricants, additives for the food and cosmetic industry, 
and many other chemicals [45]. Microorganisms regarded as an alternative oils source cannot 
presently compete directly with plants, but their use has many advantages like shorter process 
cycle, independence of season and climate, facility for genetic improvement and the possibility 
to manufacture lipid of unique structure, and nonsynthesized by plants. It should be mentioned 
that the composition of yeast oils is similar to vegetable products, and predominant fraction of 
them is made of triacylglycerols (TGA) rich in polyunsaturated fatty acids [46]. Lipids are stored 
intracellularly mainly as granular forms called “lipid body,” and their content and profile of 
fatty acids differs between species [47]. The main fatty acids formed by oleaginous yeast are the 
myristic (C14:0), palmitic (C16:0), stearic (C18:0), oleic (C18:1), palmitoleic (C16:1), and linoleic 
(C18:2) acids [48]. Two different pathways are involved in lipid accumulation by oleaginous 
yeast: de novo lipid synthesis and ex novo lipid accumulation. Fundamental differences at the 
biochemical level exist between de novo lipid accumulation from hydrophilic substrates and ex 
novo lipid accumulation from hydrophobic substrates. In contrast, ex novo lipid production is a 
growth-associated process that occurs simultaneously with cell growth and is entirely indepen-
dent of nitrogen exhaustion of the culture medium. The synthesis of ex novo lipids is the modi-
fication of fats and oils by oleaginous microorganisms [49]. The production of microbial oils 
became more important in the light of biodiesel production. The oleaginous yeast is considered 
as potential candidate for the production of “2nd generation” biodiesel deriving from lipid 
Yeast as a Versatile Tool in Biotechnology
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produced by oleaginous microorganisms growing on wastes or agro-industrial residues like 
sewage sludge, hemicelluloses, hydrolysates, waste glycerol, cheese whey, etc. [50, 51]. SCO 
may be produced via submerged fermentation performed under aerobic conditions through 
the mode of batch, fed batch, or continuous operation. To achieve both sufficient biomass for-
mation and proper lipid accumulation level, yeast must be cultivated under carefully evaluated 
conditions. Many factors have been described as influencing lipid accumulation process and 
proper medium composition seemed to be one of the most important ones [52]. After biomass 
had been formed, to promote lipid accumulation process, stress conditions must be induced. 
Lipid storage is triggered by a nutrient limitation combined with an excess of carbon. Mostly 
nitrogen limitation is used to trigger lipid accumulation, but also other nutrients as phospho-
rus and sulphur have been shown to induce lipid storage. In spite of the applicative potential, 
the commercialization of microbial products is limited to oils containing polyunsaturated fatty 
acids like docosahexanoic acid (DHA), arachidonic acid (ARA), and eicosapentaenoic acid (EPA) 
[53, 54]. Producing other microbial oils either for human consumption, industrial use, or for 
biofuel production is still cost inhibitory—currently, the production of microbial oils is more 
expensive than that of vegetable oils [55]. To extend the industrialization of yeast as alternative 
source of oils, all efforts should be focused on genetic improvement of cell factories combined 
with optimization of nutrient supply and cultivation conditions and modifications of down-
stream technology [56].
2. Yeasts as whole-cell biocatalysts
Different genera of yeasts are convenient biocatalysts applied in many fields of chemistry, 
especially for the synthesis of chiral building blocks and fine chemicals. They are interest-
ing catalytic tools, not only for their varied enzymatic activities but also for their microbio-
logical features such as simplicity of cultivation, low nutritional requirements, and adaptive 
capacities. These capacities result from their flexible metabolism, which responds to the 
environmental impacts, so the direction (also stereoselectivity) and the effectiveness of the 
biotransformations can be driven by the physical chemical parameters of the process. What 
is also important, they are susceptible to the engineering of the reaction media (e.g., water, 
organic) and to the biocatalysts form (e.g., permeabilization, immobilization). This signifi-
cantly broadens the field of their application by overcoming the limitations such as low solu-
bility of the bioconversion substrates. It can be said that yeasts are used for decades and are 
one of the first whole-cell biocatalysts applied in industrial processes.
Literature data proved that the core applications of yeasts are connected with their extraordi-
nary reductive abilities. Since it was proven that whole-cell biocatalysis is (as enzymatic one) 
chemoselective, regioselective, and stereoselective and able to regenerate dehydrogenases 
cofactors under biocatalytic conditions, yeasts were extensively examined as reductive cata-
lysts for chiral building blocks synthesis—especially chiral alcohols of defined absolute config-
uration. The activity of a number of yeasts genera has been tested toward structurally different 
ketones, and in the most cases desired, alcohols have been obtained as pure enantiomers [57]. 
Alcohols drawn below (Figure 4) represent both, simple, and more complicated—unusual 
structures obtained thanks to the whole-cell biocatalysis driven by yeasts.
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Pichia methanolica is one of the most important biocatalysts employed in industry because of its 
reductive ability and low substrate specificity. Thus,  Pichia methanolica mediated reduction of 
ethyl-5-oxo-hexanoate and 5-oxohexanenitrile led to S-alcohols: 1a and 1b (Figure 4) obtained 
with conversion degree up to 90 and 97% of ee (enantiomeric excess). What is also important, 
bioreduction of compound 1a (Figure 4) was performed successfully on the gram scale with 
the similar yield. Pichia methanolica is employed for the reduction purposes by Bristol-Mayers 
Squibb Company (USA). Alcohol 2 (Figure 4) is important for pharmaceutical industry, this 
molecule is considered as supporting drug in the diabetes type 2 therapy by elevating the rate 
of metabolisms. Application of Candida sorbophila MY 1833 allowed receiving pure product 
on the large scale level with up to 60% of conversion degree and 98% of ee. Optically pure 
diols are also important, mainly as chiral building blocks for pharmaceuticals and fine chemi-
cals synthesis. As an example—compound 3 (Figure 4)—2S, 5S–hexanediol can be received 
by diketone reduction performed with Saccharomyces cerevisiae on preparative scale, with the 
complete substrate reduction and with the de (distereomeric excess) of 96%. Except to men-
tioned diol, such procedure can be applied also for 5-hydroxyhexane-2-on formation, which 
is a substrate for chiral tetrahydrofuranes synthesis—chemicals of significant meaning for 
obtaining of the biodegradable polymers, drugs, and perfumes. Among different chiral com-
pounds with hydroxyl functionalities, there are some of special interest—they are building 
platforms for the synthesis of series compounds. Such importance can be attributed to the 
(S)-4-chloro-3-hydroxybutanoate ester (S)-CHBE (Figure 5) [58]. A number of fungal catalysts, 
e.g., Geotrichum sp., Candida sp., Aureobasidium sp. are active toward appropriate ketone, but 
the reaction proceeds with an average stereoselectivity. Among others, Pichia stipites CBS 6054 
was found as one allowed obtaining chiral product with ee of 80%. The other products of 
yeast-mediated enantioselective bioreduction are chiral bicyclic alcohols, e.g., synthons of (S)-
pramipexole (anti-Parkinson drug) (Figure 6) and also its (R) isomer—considered as an anti-
amyotrophic lateral sclerosis (ALS) agent [59]. Chirality is introduced into these molecules by 
the prochiral bicyclic ketone (Figure 6) reduction mediated by Sachcaromyces cerevisiae, and this 
is the crucial step of the sequences of the reaction leading to the final enantiomers of pramipex-
ole. Discussed objective is also an example of the yeast biotransformation of the compounds 
with heteroatoms in their structures—here, sulphur atom is an element of the bicyclic.
Reductive activity of Saccharomyces cerevisiae is also applied for some nontypical reactions 
such as geraniol into citronellol hydrogenation achieved with resting yeast cells on prepara-
tive level (Figure 7) [60]. Process productivity reaches 2.38 g/L for the reaction carried out in 
the continuous-closed-gas-loop bioreactor.
Entirely a different activity of yeasts as biocatalysts found some practical application, lately. 
Successful experiments with Saccharomyces cerevisiae were performed according to Figure 8 
R
OH
1a (R=CO2Et)
1b (R=CN)
NO2
N
OH H
O
2
OH
OH3
Figure 4. Alcohols synthesized using whole yeasts cells.
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Figure 7. Structures of geraniol and citronellol.
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Figure 6. Pramipexole (2-amin-6-propylamino-4,5,6,7-tetrahydrobenzothioazole).
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[61], which illustrates the addition of diverse 3-substituted indol derivatives to nitroolefines. 
Chemical synthesis of such substituted indols requires some hazardous organic solvents, 
while biological synthesis significantly reduces this problem and offers easy operated and 
effective system (yield of the reaction range between 72 and 90%).
Such indol motifs are crucial part of the biologically active compounds such as arbidol (influ-
enza A and B virus treatment and prophylactic); golotimod (immunostimulating, antimicro-
bial, and antineoplastic agent); and panobinostat (acute myeloid leukemia treatment; Figure 9).
3. Yeast’s enzymes applications
Biocatalysis includes both biotransformations (e.g., the conversion of xenobiotics using whole 
cells or resting cell systems) and enzyme catalysis (e.g., the conversion of xenobiotics using 
N
R
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R
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R
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R
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R
3
NO2
biocatalyst
Figure 8. Biocatalyzed addition of indoles to nitroolefins.
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Figure 9. Compounds with the indol-motif.
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cell-free extracts or purified enzymes) [62]. Although both whole cells and isolated enzymes 
can be used as biocatalysts, whole cells are very often preferable because they are more stable 
and cheap sources than purified enzymes, without the need for purification and coenzyme 
addition. However, in the case of single-step biotransformation, isolated enzymes can be con-
sidered as a better choice and can be used as a free or immobilized biocatalyst either in aque-
ous or organic media [63]. Yeasts, especially Saccharomyces species, are primarily known from 
whole cell reductive activity [64, 65] and are used in the food industry for the production of 
alcoholic beverages as well as for bread fermentation [3]. However, yeasts are a source of 
enzymes such as: lipases, dehydrogenases, or invertase.
3.1. Yeast’s lipases
Lipases are widely distributed in nature and are produced by plants, animals, and microorgan-
isms. Microbial enzymes are more useful than the other ones because of the diversity of cata-
lytic activities, simplicity of manipulations, and low cost production (extracellularly during rapid 
growth on inexpensive media) [66]. Additionally, microbial enzymes are free from problems 
associated with contamination with hormones, viruses, and can be used in food processing and 
pharmaceutics productions for vegetarian or kosher diets [67]. Microbial lipases (EC 3.1.1.3) are 
suitable enzymes for organic synthesis because they are active toward broad range of nonphysio-
logical substrates and are stable in biphasic systems or pure organic media. Lipases can be applied 
for either of lipid modifications and synthesis of special compounds: pharmaceuticals, polymers, 
biodiesels, and biosurfactants [68]. Under physiological conditions, lipases catalyze hydrolysis of 
ester bond in triacylglycerol to glycerol and free fatty acids. Under nonaqueous conditions, they 
catalyze the reverse process—esterification. The term transesterification refers to exchange the 
group between an ester and acid, ester and alcohol, or at least between two esters (Figure 10) [69].
R OR'
O
R XH
O
+ H2X
organic media
Esteryfication
Hydrolysis
aqueous media
+ R'OH
R OR'
O
+ R"XH
organic media
Transesteryfication
R XR"
O
+ R'OH
 
Figure 10. Types of reactions carried out by lipases.
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Mentioned features make them significant biocatalyst for various applications. There are a certain 
number of yeast species able to produce lipases, most of them belong to Candida genus: Candida 
utilis, C. rugosa (cylindracea), C. antarctica, C. viswanathii, and additionally, Yarrowia lipolytica [70].
3.1.1. Hydrolysis
For pharmaceutical industry, lipases are used to resolve racemic mixtures of alcohols or car-
boxylic acids through asymmetric hydrolysis of acyl derivatives. Candida antarctica lipase, 
isoform B (CAL-B) is one of the most employed psychrophilic lipases for many different 
applications (kinetic resolutions, desymmetrization, aminolysis, etc.) [71]. Commercial 
CAL-B is available either in free, lyophilized, and immobilized forms (onto Lewatit VP OC 
1600 (poly(methyl methacrylate-co-divinylbenzene)—Novozyme 435, Chirazyme L2-C2). 
Novozym 435 is a suitable catalyst for both small organic molecules [72, 73] and for polym-
erization reactions [74, 75]. Also, the immobilization of CAL-B onto different supports may 
result in different activity and enantioselectivity (Table 1) and may be a tool of control of 
selectivity of the hydrolysis. This feature was used for the resolution of racemic mixture of 
2-O-butyryl-2-phenylacetic acid—precursor of both enantiomers of mandelic acid (Figure 11) 
and for the enantioselective hydrolysis of 3-phenylglutaric dimethyl diester—precursor in 
the drug synthesis (e.g., HIV inhibitor) [76]. As it is shown in the Table 1, it is possible to 
change the enantioselectivity of biocatalyst just by simple replacement of one support mate-
rial to another one (Figure 11).
Another possible way to change the enantioselectivity of hydrolysis is the addition of the 
organic co-solvent to reaction medium. In organic media, the conformation of enzyme 
appears to be more rigid which may influence the enantioselectivity of the reaction. For the 
Candida rugosa, lipase-catalyzed hydrolysis of various substituted phenoxypropionates, the 
addition of 30–70% dimethyl sulfoxide (DMSO) or sodium dodecyl sulfate (SDS) improved 
the enantioselectivity, (E = 4 to >100) [77, 78]. For the same lipase (C. rugose), complete 
Biocatalyst Activity
μmolg
cat
−1 
h
−1
ee p (%)1 Stereochemical 
preference
E2
Novozym 435 0.75 >99 S >100
NOVO-CAL-B 0.56 >99 S >100
Lewatit-CAL-B 0.55 >99 S >100
Octyl-agarose-CAL-B 0.19 95 R 49
Octadecyl-sepabeads-CAL-B 0.35 90 R 23
Butyl-agarose-CALB-B 0.16 72 R 7.5
Optical purity of product.
Enantioselectivity of the enzyme towards substrate.
Table 1. The influence of different methods of immobilization on the activity and enantioselectivity of CAL-B applied for 
hydrolytic resolution of 2-O-butyryl-2-phenylacetic acid.
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reversal of enantioselectivity of hydrolysis of 1,4-dihydropyridines was observed in differ-
ent organic solvents saturated with water [79], this allowed to obtain both enantiomers of 
1,4-dihydropiridine (Figure 12).
N
H
NO2
COORHOOC
CH3H3C N
H
NO2
COORHOOC
CH3H3C
N
H
NO2
COORHOOC
CH3H3C
C. rugosa lipase
i-Pr2O/water
(S)-product                                                    (R,S)-substrate
(R)-product
C. rugosa lipase
cyclohexane/water
Figure 12. Reversal of enantioselectivity in hydrolysis catalyzed by Candida rugosa lipase in organic solvent saturated 
with water [79].
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Figure 11. Kinetic resolution of 2-O-butyryl-2-phenylacetic acid by immobilized CAL-B on different supports.
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Candida antarctica produces two isoforms of lipases (A and B). However, more attention has 
been directed to the application of CAL-B, but in the last few years, also CAL-A has found 
remarkable applications. The most surprising biochemical property of CAL-A is its high ter-
mostability of over 90°C [71, 80]. It is quite strange that rather psychrophilic microorganism 
produces thermostable enzyme. This feature allows using the CAL-A under unique reaction 
conditions [81] and towards unusual substrates, especially sterically hindered tertiary alcohols 
and their derivatives or bulky cyclic compounds. Bioconversion of tertiary alcohols can be use-
ful for the removal of tert-butyl protecting group even under high temperature (Table 2) [82]. 
Several examples of such applications are summarized in Table 2.
Another interesting application of CAL-A is the regioselective hydrolysis of cyclic diacetates, 
useful building blocks for the synthesis of vitamin D
3
 derivatives [83], or hydrolysis of differ-
ent sterically hindered carboxylic acids [84].
3.1.2. Esterification and transesterification
The most important application of lipases in organic synthesis is esterification important for 
the resolution of racemic mixtures of secondary alcohols and carboxylic acids. Chiral second-
ary alcohols serve as intermediates for pharmaceutical synthesis [85–87]. Lipase-catalyzed 
Table 2. Examples of substrate structures accepted by CAL-A–protecting group removal.
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methods available for the preparation of enantiopure compounds are kinetic resolution (KR), 
dynamic kinetic resolution (DKR), and desymmetrization. Enzymatic kinetic resolution is 
based on the difference between the reaction rates of the enantiomers of a racemate at the 
presence of chiral catalyst—enzyme. Dynamic kinetic resolution combines kinetic resolution 
with the in-situ racemization of the unreacted enantiomer. Racemization can be performed 
chemically or enzymatically. The kinetic resolution of secondary alcohols and esters is car-
ried out in organic solvents with lipase catalyzed acylation and alcoholysis. It leads to the 
formation of one enantiomer obtained as an alcohol and the other one as an ester. The maxi-
mum theoretical yield for each enantiomer is 50%. C. antarctica enzymes are often used for the 
resolution of secondary alcohols, mostly with bulky group [88, 89] but also for resolution of 
aliphatic compounds [90]. As an example—CAL-B was applied for the resolution of racemic 
mixture of 2-pentanol in heptane—media (yield (49,6%) and ee >99%) (Figure 13). S-(+)-2-
pentanol is a key chiral intermediate for synthesis of anti-Alzheimer drugs, which inhibit 
β-amyloid peptide release and/or its synthesis [91, 92].
C. rugosa is the producer of lipase employed for the resolution of profens (2-aryl propi-
onic acids) in enantioselective transesterification process. Profens are an important group of 
nonsteroidal anti-inflammatory drugs, and their biological activity depends on the optical 
purity of the compounds, mainly (S)-enantiomer [93]. For instance, (S)-ibuprofen ((S)-2(4-
isobutylphenyl) propionic acid) is 160 times more effective than (R)- isomer in the inhibi-
tion of prostaglandins synthesis. Optically, pure profens can be synthesized by asymmetric 
chemical synthesis, catalytic kinetic resolution, and chiral chromatography [69], but enzy-
matic enantioselective esterification seems to be the best method (Figure 14). Discussed 
reaction was carried out in saturated cyclohexane with 1-propanol or 2-propanol as acyl 
agents and completed with good conversion degree and excellent enantiomeric excess of 
(S)-ibuprofen [94].
Also, enantiomerically pure amines constitute a class of compounds with possible biologi-
cal properties and industrial applications [95]. Candida antarctica lipase B is one of the most 
effective catalyst in the preparation of enantiomerically pure nitrogenated compounds (e.g., 
amines, amides, amino acids, amino alcohols, etc.). This is achieved by enantioselective acety-
lation [96]. For example, resolution of aminoalkylpyridines was most effective (conversion 
50%, time 4h, ee of product, and substrate >99%) with the use CAL-B and ethyl acetate as an 
acyl donor in the tert-butyl methyl ether (TBME-medium) (Figure 15) [97].
CAL-A isoform of C. antarctica lipase is able to selectively acylate cyclic, sterically hindered 
structures via kinetic resolution (Figure 16) alicyclic β-aminocarboxylic acids esters—
OH
CAL-B
O
OO
OH
+
O
OH
O
O
Racemic 2-pentanol
(S)-2-pentanol
(R)-2-pentyl hemisuccinate
Succinic anhydride
 
Figure 13. Kinetic resolution of 2-pentanol by esterification.
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building blocks for the synthesis of various pharmaceutical important heterocycles [81] 
are synthesized this way. The best activity and enantioselectivity were observed in diethyl 
ether or diisopropyl ether with 2,2,2-trifluoroethyl hexanoate as an acyl donor.
CAL-A is also active towards sterically hindered tertiary alcohols. This feature is quite unique 
among hydrolases. The first example of enantioselective kinetic resolution of racemic mixture 
N
R
Cl
NH2
Racemic amine
R: Me, Et, Pr
CAL-B
EtOAc
TBME
N
R
Cl
NHAc
N
R
Cl
NH2
+
(R)-amide                     (S)-amine
 
Figure 15. Kinetic resolution chloro-aminopyridines.
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+
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(R)-ibuprofen
(S)-ibuprofen ester
Figure 14. Enantioselective esterification of (R,S)-ibuprofen.
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Figure 16. Kinetic resolution of alicyclic amino acids.
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of tertiary alcohol was acylation of 2-phenylbut-3-yn-2-ol. The reaction was quite enantiose-
lective, but the yield was rather moderate (25%) because of the steric hindrance. Another 
interesting application of CAL-A is selective acylation of sterols [98], furyl substituted allyl 
alcohol [99], or cyanohydrins [100, 101].
3.2. Yeast’s invertase
Invertase (β-fructofuranosidase- EC 3.2.1.26) catalyses hydrolysis of the glycoside bond from 
the terminal nonreducing beta-fructofuranoside side in disaccharide [102]. It is also widely 
distributed in the environment, mainly in plants and microorganisms. The most important 
application of invertase is production of invert syrup—equimolar mixture of fructose and 
glucose, released from sucrose (Figure 17), which is used in food and beverage industries. 
Monosaccharides mixture is sweeter than sucrose and hygroscopic, it mainly is used for pro-
duction of soft-centered candies and fondants. Invertase is also applied for the manufacture 
of artificial honey, plasticizing agents for cosmetics, pharmaceutical and paper industries, and 
enzyme electrodes for the detection of sucrose [103, 104]. Additionally, it can be applied for 
the synthesis of probiotic oligosaccharides like non-digestible oligosaccharides (NDO), e.g., 
lactosucrose [105]. Commercially invertase is produced mainly by Saccharomyces  cerevisiae 
(Baker’s yeast) or Saccharomyces carlsbergensis. In yeast cells, invertase is produced either in 
intracellular or extracellular form [106].
3.3. Yeast’s oxidoreductases
Enantiometrically pure alcohols including α- and β-hydroxyesters are important and valu-
able intermediates in the synthesis of pharmaceuticals and other fine chemicals [107]. 
Enantioselective ketone reductions are one of the most common methods applied for opti-
cally pure alcohols productions. Because reactions catalyzed by dehydrogenases/reductases 
require cofactors (NADH or NADPH), the use of whole cells rather than isolated enzymes is 
preferred, to decrease the cost of enzyme purification and cofactor regeneration. However, 
isolated dehydrogenases employment decreased product purification problems (Figure 18).
Generally, α-ketoesters are reduced with lower enantioselectivities by whole yeast cells, so pair 
of purified reductases are selected to produce both enantiomers of (S)-ethyl-3-hydroxybutyrate 
CH2OH
O
H
O
HO
OH
HO
O
HO
OH
OH
OH
Invertase
O-glycosidic bond
 
Figure 17. Hydrolysis of sucrose by invertase.
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(pharmaceutical building block) in optically pure forms on preparative scale [108]. Reduction 
of β-ketoesters depends on both structure of substrate and specificity of the enzyme and usu-
ally yields in desired enantiomer of high optical purity [109].
Saccharomyces are also known as a producers of old yellow enzyme (OYE), the first discov-
ered and characterized flavoprotein [110], which can be used for double bond reduction 
(Figure 19) or for dismutation reactions toward cyclic substrates (Figure 20) [111] and also for 
the reduction of nitrate esters [112] with the addition of coenzyme—NADPH.
Other example of reductase is selective carbonyl reductase from Candida magnolia, active toward 
the structurally different ketones, reduced to the corresponding optically pure (R)- aryl and ali-
phatic alcohols. This enzyme also catalysis reduction of ketones with anti-Prelog enantioselectiv-
ity which is an unusual feature of bioreductions (Figure 21) [107]. Configuration of obtained aryl 
alcohols is mostly R—enantiomers but also strongly dependent on R group structure (Figure 21).
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Figure 18. Reduction reactions catalyzed by dehydrogenases. Cofactor regeneration circle.
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Figure 19. Example of reduction of double bonds catalysed by OYE.
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4. Yeast’s applications in molecular biology
Yeasts of the Saccharomyces genus, in particular S. cerevisiae, are one of the fundamental models 
for eukaryotic organisms, commonly used in genetic and molecular biology studies. S.  cerevisiae 
is a unicellular organism that can be grown on defined media, which gives the complete con-
trol over its chemical and physical environment. Culturing yeast is simple, economical, and 
rapid and can be conducted under aerobic and anaerobic conditions. As a nonpathogenic and 
nontoxic organism, they are safe for laboratory work, without any special precautions. Big 
accessibility as well as easy culturing on both liquid and solid medium makes yeast cheap and 
handy organism with significant biotechnological capabilities.
Although yeast and humans have been evolving along separate paths for 1 billion years, 
still a substantial amount of yeast genes exhibit high homology to mammalian ones. Since 
the basic cellular mechanics of replication, recombination, cell division, and metabolism 
are generally conserved between yeast and larger eukaryotes, they constitute a good 
model for studying different processes such as aging, regulation of gene expression, sig-
nal transduction, cell cycle, metabolism, apoptosis, neurodegenerative disorders, and 
many more [113]. Furthermore, its protein expression systems have more in common with 
higher organisms than with prokaryotic ones, mainly due to the posttranscriptional and 
posttranslational processing, which makes it a great candidate for acquiring a number of 
industrially or medically significant biomolecules, such as recombinant proteins for phar-
maceutical purposes [114].
O
OYE
3-oxodecalin-4-ene
OHO
H
H
+
3-hydroxy-
6,7,8,9-tetrahydronaphtalene
3-oxodecalin
 
Figure 20. Dismutation reaction calalysed by OYE.
Figure 21. Anti-Prelog reduction of ketones by C. magnoliae reductase.
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Life cycle of Saccharomyces cerevisiae strains include haploid and diploid phase, both of 
which typically grow asexually by budding. The cell cycle consists of four distinct phases 
(G1, S, G2, and M) and is regulated in a similar way to that of the cell cycle in larger eukary-
otes [115]. Haploid yeast cells can be either mating type a or α and under normal condition 
can mate together to generate a/α diploids. The diploid cells cannot mate but can reproduce 
asexually by budding like haploids. However, under specific circumstances, like unfavor-
able environment conditions (lack of nutrients), diploid cell can undergo meiosis to pro-
duce haploid spores. Subsequently, the newly produced haploid nuclei are packaged into 
four spores that contain modified cell walls, resulting in structures that are very resistant 
to environmental stress [116]. Each single haploidic spore from tetrad arising after meiosis 
can be isolated and analyzed by various micromanipulation methods. It provides a unique 
opportunity to study the coupling between genes among many others. Haploid states cell 
can be also used for recessive mutation studies, while diploid strains can be exploited for 
complementation tests.
S. cerevisiae have also been first eukaryotes whose genome has been fully sequenced and pub-
lished in 1996. Its nucleus genome constitutes of 12,068 kb organized into the haploid set of 
16 chromosomes ranging in size from 200 to 1600 kb. The characteristic feature is that yeast 
genome is much more compact in comparison to other eukaryotic relatives, with genes rep-
resenting 70% of total sequence. It possesses around 5885 potential protein-encoding genes, 
approximately 140 genes specifying ribosomal RNA, 40 genes for small nuclear RNA mol-
ecules, and 275 transfer RNA genes. Currently, an international, multidisciplinary team is 
involved in the production of 16 chromosomes of S. cerevisiae by synthetic biology tools, and 
the results are expected at the end of the year [117]. Another highly unique and unusual, as for 
eukaryotes, feature of S. cerevisiae genome is the presence of DNA plasmids that enables a vari-
ety of genetic manipulations and are of great importance for modern molecular biology [118].
Techniques used for yeast transformation and specific selection have been well described. For 
this purpose, shuttle vectors are commonly used due to the fact that they can transform both 
yeast and bacteria, such as Escherichia coli. Various yeast strains carry different auxotrophic 
markers that can be generated by genetic engineering methods, for instance, by gene deletion in 
amino acid biosynthesis pathways. Scientists have developed a number of bifunctional vectors 
that are easy to isolate and can autonomously replicate in each yeast and bacteria cells.
4.1. Yeast’s plasmid vectors
Saccharomyces cerevisiae is a very important microorganism in modern biotechnology, not only 
for its contribution to brewing and bread-making industry, but also for showing great potential 
in the field of molecular biology and biomedicine due to its unique form of genetic material 
and protein expression systems. S. cerevisiae is one of very few eukaryotic organisms that con-
tain circular DNA in the form of plasmids. Almost every strain of this yeast has the 2-μm plas-
mid, which can constitute the outstanding basis for cloning vectors (Figure 22), as it is 6 kb in 
size and is equipped with four following elements: origin of replication; genes REP1 and REP2 
that code for proteins involved in replication process; FLP gene that is utilized by the plasmid 
to switch between isoforms, and gene D which role is not established yet [119]. In order for 
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2-μm plasmid to work as a fully functional cloning vector, there has to be an incorporated 
element, called a selective marker, which allows for the transformed cells to be identified after 
cloning experiment.
Most of the bacterial vectors are provided with genes-encoding resistance to various kinds of 
antibiotics, such as ampicillin (ampR) or tetracycline (tetR). Therefore, upon culturing trans-
formed cells in the medium with the addition of such antibiotic, the colonies that were unable 
to grow did not carry the resistance gene (hence, the uptake of the vector did not occur); thus, 
the only cells that survive are the transformed ones carrying the properly inserted vector.
Cloning techniques with yeast differ mostly in the strategic approach of the selective mark-
ers. In this case, usually a special kind of organism is required as the host, namely an 
auxotrophic mutant that is unable to obtain or synthesize a pivotal compound of one of its 
metabolic pathways. A good example is leu2− yeast that has an inactive form of LEU2 gene; 
hence, it cannot synthesize leucine and can only grow in a medium that is supplied with this 
amino acid. To properly use that organism as the host, a vector with LEU2 active gene has 
to be prepared. The cells are then transformed with the plasmid and cultured in minimal 
medium that lacks leucine. This way the only colonies that will grow will be the transformed 
cells [120].
There are few kinds of yeast cloning vectors, but all of them are so-called shuttle vectors, 
which means that they can replicate and be selected in both bacteria and yeast. Shuttle vectors 
were developed mostly because plasmid preparation from yeast only is highly ineffective; 
hence, the large-scale DNA propagation and convenient genetic manipulation are performed 
in bacterial organism, such as Escherichia coli.
Yeast cloning vectors based on 2-μm plasmid are called yeast episomal plasmids (YEps) 
(Figure 23(a)). Depending on the kind of YEp, they can either contain most of the 2-μm plasmid 
or just the origin of replication, their backbone is usually constructed from E. coli vectors, such 
Figure 22. Genetic structure of 2 μm yeast plasmid.
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as pBR322 that contains genes encoding resistance for antibiotics, like ampicillin or tetracycline. 
As the name suggests, YEps can replicate independently, or they can be integrated into one of 
the yeast chromosomes. The most common reason for YEps integration is that they carry selec-
tive marker gene, which is very similar to the mutant chromosomal DNA of the host organism; 
for example, the already mentioned LEU2 gene or others, such as URA3, HIS3, TRP1, or LYS2 all 
involved in biosynthesis pathways of pyrimidine nucleotides, histidine, tryptophan, or lysine, 
respectively. YEps are considered as high copy number vectors, yielding up to 200 copies per 
cell with the transformation frequency between 10,000 and 100,000 transformed cells per μg. 
Unfortunately, the major drawback is that their recombinants are highly unstable, which makes 
it very difficult and time consuming to achieve conclusive and reliable results when working 
with YEps.
The other important type of yeast vectors are yeast integrative plasmids (YIps) (Figure 23(b)). 
They mainly consist of E. coli plasmid, such as pBR322 and a selective marker (usually one 
of the mentioned above). What is important is they do not contain yeast origin of replication; 
therefore, they cannot replicate in any other way than through the process of integration with 
chromosomal DNA. In terms of transformation frequency, YIps come at the very last place 
with the number significantly lower than 1000 transformed cells per μg and usually only one 
copy per cell. On the other hand, their recombinants are very stable, usually making them the 
top pick for the experimental purposes.
Yeast replicative plasmids (YRps) (Figure 23(c)) are another type of yeast cloning vectors. 
They contain a backbone from E. coli vector, the yeast origin of replication in close proximity 
to the selective marker. Such structure suggests that YRps can replicate independently with 
relatively high transformation frequency ranging from 1000 to 10,000 transformed cells per 
μg and a number of copies between 5 and 100 per cell. YRps recombinants are as unstable as 
the YEps ones, making them one of the last choice for laboratory work.
Along with the time, there was a growing demand for much larger pieces of DNA to be 
manipulated through the techniques of genetic engineering. It was at this point that the last 
type of yeast cloning vectors was developed, namely the yeast artificial chromosomes (YACs). 
The general idea behind those constructs was that yeast chromosomes usually carry sev-
eral hundred kilobases of genetic material, so why not imitate the native DNA? YACs were 
thought to contain the three key elements of a chromosome:
Figure 23. Genetic structure of exemplary yeast vectors. AmpR and tetR are the antibiotic resinstance genes from E. coli 
pBR322 plasmid, whereas LEU2, URA3, TRP1 fragments represent yeast chromosomal DNA: (a) yeast episomal plasmid 
YEp13, (b) yeast integrative plasmid YIp5, (c) yeast replicative plasmid YRp7.
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• centromeres required for the proper chromosome positioning during the cell division;
• origins of replication, which are the places on chromosome where the replication of genetic 
material starts;
• telomers as the defenders of the chromosomes against exonucleases.
Several types of YACs have been developed over the years, they usually consist mostly of a 
E. coli pBR322 plasmid with some yeast genes, such as selective markers (usually at least two 
located oppositely), origin of replication, gene CEN4 coding for centromere region, the two 
telomeres fragments TEL, and an additional selective marker with a restriction enzyme site, 
such as SUP4 gene that compensates for a mutation-causing accumulation of a red pigment 
(Figure 24). YACs are equipped with a restriction enzyme site between two TEL sites, so that 
upon cleavage, an “artificial” linear chromosome is created, subsequently SUP4 is cut, and the 
chromosome is divided into two arms, between which a DNA fragment to be cloned is ligated, 
thus recreating the single-line chromosome structure. The next step is to transform double 
auxotrophic mutant organisms that will not be able to survive in the minimum medium with-
out the properly received YAC. Additional experimental control can be then tested by simple 
optical inspection—colonies with disrupted SUP4 gene will appear as white, meaning they are 
transformed, any other color means that the colony has not been properly transformed [121].
Figure 24. Genetic structure of yeast artificial chromosome pYAC3.
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4.2. Yeast expression system
Recombinant proteins are the biomolecules of great importance, because among other things, 
they are able to mimic the functions of native proteins; hence, they are extensively studied in 
biotechnology and biopharmaceutical research. The critical point of target protein production 
is the choice of efficient expression system which enables obtaining functional product with 
high yield.
Yeast expression system constitutes a good alternative for widely used bacterial and higher 
eukaryote expression systems. They are genetically well defined and are known to perform 
many posttranslational modifications, including proper protein folding, disulfide bond for-
mation, and glycosylation [122]. The culturing of yeast is also easy, rapid, and cheap, which 
is their big advantage over the insect or mammalian cells. They easily undergo genetical 
manipulation and adapt to fermentation processes; therefore, using yeasts as a cell factory 
is convenient and enables to obtain a fair amount of target protein. In contrast to bacteria, 
recombinant proteins obtained in yeast expression systems are free of endotoxins that make 
this system safer, especially in terms of medical and food application [114]. In fact, about 20% 
of all biopharmaceuticals are produced by S. cerevisiae. Among them, the most dominant are 
insulin, human serum albumin, hepatitis vaccines, and virus-like particles used for vaccina-
tion against human papillomavirus [123].
However, yeast cells are limited in the production of human-like glycoproteins by their inabil-
ity to produce complex N-linked glycans. In addition, S. cerevisiae produce the hypermanno-
sylated N-linked glycans with the mannose residues being attached to the chitobiose core (a 
dimmer of β-1,4-linked glucosamine units). Hypermannosylation also results in a short half 
life in vivo and thereby compromises the efficacy of most therapeutic glycoproteins [124]. To 
overcome this issue, great deal of effort has been put into altering the glycosylation pathways 
in P. pastorsis to produce strains possessing human-like N-glycosilation patterns [125, 126]. 
This achievement has contributed to the increased usefulness of yeast in industry for the pro-
duction of stable and recombinant glycoproteins.
There is no ultimate procedure for yeast expression system that could work equally well for 
the production of all kinds of proteins. Optimization of whole process is the critical step to 
obtain sufficient amounts of pure, properly folded and secreted protein of interest. While 
small and simple in structure proteins are easy to obtain, the big and multi-domain protein 
could require certain chaperones to facilitate the folding process [127]. The advantage of yeast 
expression system is that it allows extracellular secretion of produced protein when proper 
signaling sequence has been attached to the structural gene [114]. It significantly facilitates 
the recombinant protein purification process from the culturing medium and allows to opti-
mize the culturing conditions. In order to increase protein secretion level, a few strategies 
have been developed. One of them is protein engineering of a desired product, for instance 
by modifying protein coding sequences and signaling sequences [128–130]. Since this meth-
odology is highly specific against each protein, the conditions optimized for one protein do 
not always work for another. Different approach is to engineer the host strains and tune-up 
folding and secretory machinery by overexpression or deletion genes that are critical for the 
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protein secretion [131, 132]. Additionally, it has been shown that expression in low tempera-
tures enhances the level of secretion [133].
There are numerous varieties of expression vectors available for producing heterologous pro-
teins in yeast, and these are the derivatives of YIp, YEp, and YRp plasmids described previ-
ously. The DNA coding for the protein of interest is inserted into the vector. The type of 
selective marker and promoter strength are key factors that determine the plasmid copy num-
ber and the mRNA level of the recombinant protein. Varieties of inducible and constitutive 
promotors have been applied for gene expression in yeasts in the past. The first of these allow 
the controllable gene expression. Most of inducible promoters are responsive to catabolite 
repression or react to other environmental conditions, like in-cell iron concentration, stress, or 
lack of essential amino acids. GAL promoter, which is induced by adding galactose, provides 
a straightforward system for expression regulation of the cloned foreign gene [134]. Another 
good example can be CUP1 promoter, which is induced by copper [135] or heat shock factor 
promoter, induced by heat stress at 39°C [136]. There are also some other groups of promoters 
that initiate strong and constitutive expression. TEF1 promoter, as an example of S. cerevisiae, 
is a widely used representative of this group, as it can drive high gene expression in both high 
and low glucose conditions [137]. Selection of a suitable promoter depends on specific process 
requirements and the properties of the target protein to be produced.
Additionally, yeasts are recognized as a generally recognized as safe (GRAS) organism, which 
only strengthens its position as the most frequently used microbial eukaryote for recombinant 
protein synthesis.
4.3. Yeast’s two hybrid system
Ever since the Field and Song discovery described in 1989, a new approach toward the 
examination of protein-protein interactions emerged, it was named as the yeast two-hybrid 
system. It allows to detect the interaction of two proteins in the yeast cell, and it can be used 
to select an interacting partner of a known protein. This technique takes the advantage of 
the fact that majority of eukaryotic transcriptional factors, such as Gal4p, consist of two 
independent, functional DNA domains: binding domain (BD) and transcription activation 
domain (AD). While the two domains are normally on the same polypeptide chain, the tran-
scription factor also functions when these two domains are brought together by noncovalent 
protein-protein interactions. In yeast hybrid system, each of these domains is connected to 
the one from the studied protein. As a result, two fusion proteins are created: one combined 
to DNA-binding domain (BD) and the other joined to activation domain (AD) [138]. The 
genes coding for both fusion proteins are carried by different plasmids, but each plasmid 
undergoes expression in the same yeast cell. If the interaction between studied proteins 
occurs, BD and AD domains are close enough to activate transcription of a reporter gene 
that is regulated by the transcription factors.
General idea of the yeast two-hybrid system can be represented by an example of transcrip-
tional factors and a gene coding for β-galactosidase, wherein the interaction between studied 
proteins may potentially lead to the expression of the reporter gene coding for β-galactosidase 
in E. coli lacZ reporter gene. The presence of this enzyme can later be verified by simple reac-
tion with X-gal, which yields a blueish insoluble product, thereby confirming or denying the 
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association of studied proteins. Since 1989, yeast two-hybrid system has been studied exten-
sively and further developed to find countless new applications, some of which are summa-
rized and generally described in Ref. [139].
5. Conclusions
Discussed unique yeasts features, which are fundamental for their versatile applications are 
still examined and after finishing the “Synthetic Yeast Genome Project (Sc2.0)” the new per-
spectives of the applying them will be opened as well as in the molecular biology and in the 
industrial applications.
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